Lifeward Ltd. Files 8-K/A Amendment

Ticker: LFWD · Form: 8-K/A · Filed: Jan 8, 2025 · CIK: 1607962

Lifeward LTD. 8-K/A Filing Summary
FieldDetail
CompanyLifeward LTD. (LFWD)
Form Type8-K/A
Filed DateJan 8, 2025
Risk Levellow
Pages2
Reading Time3 min
Sentimentneutral

Sentiment: neutral

Topics: amendment, financial-statements, exhibits

TL;DR

Lifeward Ltd. (formerly ReWalk Robotics) filed an amendment to its 8-K on Jan 8, 2025, updating financial statements/exhibits.

AI Summary

Lifeward Ltd. filed an amendment (8-K/A) on January 8, 2025, to its current report originally filed on January 7, 2025. This amendment pertains to financial statements and exhibits. The company, formerly known as ReWalk Robotics Ltd., is incorporated in Israel and has its principal executive offices in Marlborough, MA.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to the initial disclosure, which could be important for investors to review for the most accurate company information.

Risk Assessment

Risk Level: low — This is a routine amendment filing for financial statements and exhibits, not indicating any new material events or significant changes.

Key Players & Entities

FAQ

What is the purpose of this 8-K/A filing?

This filing is an amendment (Amendment No. 1) to a previously filed Form 8-K, specifically related to Financial Statements and Exhibits.

When was the original report filed, and when was this amendment filed?

The earliest event reported was on January 7, 2025, and the amendment (8-K/A) was filed as of January 8, 2025.

What is the current name of the registrant, and what were its former names?

The current name is Lifeward Ltd. Its former names include ReWalk Robotics Ltd. and Argo Medical Technologies Ltd.

In which jurisdiction is Lifeward Ltd. incorporated?

Lifeward Ltd. is incorporated in Israel.

What is the principal executive office address for Lifeward Ltd.?

The principal executive offices are located at 200 Donald Lynch Blvd., Marlborough, MA 01752.

Filing Stats: 645 words · 3 min read · ~2 pages · Grade level 8.5 · Accepted 2025-01-08 16:30:17

Filing Documents

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits 4.1* Form of Ordinary Warrant. 4.2* Form of Placement Agent Warrant. 5.1 Opinion of Goldfarb Seligman & Co. (previously filed as Exhibit 5.1 to Lifeward Ltd.'s Current Report on Form 8-K filed with the SEC on January 8, 2025). 10.1 Form of Securities Purchase Agreement (previously filed as Exhibit 10.1 to Lifeward Ltd.'s Current Report on Form 8-K filed with the SEC on January 8, 2025). 23.1 Consent of Goldfarb Seligman & Co. (contained in Exhibit 5.1) (previously filed as Exhibit 23.1 to Lifeward Ltd.'s Current Report on Form 8-K filed with the SEC on January 8, 2025). 99.1 Press release dated January 7, 2025 (previously filed as Exhibit 99.1 to Lifeward Ltd.'s Current Report on Form 8-K filed with the SEC on January 8, 2025). 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. * Filed herewith

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Lifeward Ltd. Dated: January 8, 2025 By: /s/ Mike Lawless Name: Mike Lawless Title: Chief Financial Officer

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing